Assessment of PLGA-PEG-PLGA Copolymer Hydrogel for Sustained Drug Delivery in the Ear
Liang Feng, Jonette A. Ward, S. Kevin Li, Gaurav Tolia, Jinsong Hao and Daniel I. Choo
Pages 279-286 (8)
Temperature sensitive copolymer systems were previously studied using modified diffusion cells in vitro for intratympanic
injection, and the PLGA-PEG-PLGA copolymer systems were found to provide sustained drug delivery for
several days. The objectives of the present study were to assess the safety of PLGA-PEG-PLGA copolymers in intratympanic
injection in guinea pigs in vivo and to determine the effects of additives glycerol and poloxamer in PLGA-PEGPLGA
upon drug release in the diffusion cells in vitro for sustained inner ear drug delivery. In the experiments, the safety
of PLGA-PEG-PLGA copolymers to inner ear was evaluated using auditory brainstem response (ABR). The effects of the
additives upon drug release from PLGA-PEG-PLGA hydrogel were investigated in the modified Franz diffusion cells
in vitro with cidofovir as the model drug. The phase transition temperatures of the PLGA-PEG-PLGA copolymers in the
presence of the additives were also determined. In the ABR safety study, the PLGA-PEG-PLGA copolymer alone did not
affect hearing when delivered at 0.05-mL dose but caused hearing loss after 0.1-mL injection. In the drug release study,
the incorporation of the bioadhesive additive, poloxamer, in the PLGA-PEG-PLGA formulations was found to decrease
the rate of drug release whereas the increase in the concentration of the humectant additive, glycerol, provided the opposite
effect. In summary, the PLGA-PEG-PLGA copolymer did not show toxicity to the inner ear at the 0.05-mL dose and
could provide sustained release that could be controlled by using the additives for inner ear applications.
Auditory brainstem response, Cidofovir, Drug delivery, Ear, Hydrogel, Sustained release.
3225 Eden Avenue, Rm 136 HPB, University of Cincinnati, Cincinnati, OH 45267-0004, USA.